What “99% Purity” Actually Means for a Research Peptide

When a peptide is advertised at '99% purity,' the number almost always refers to chromatographic purity by HPLC: the area of the target peptide peak as a fraction of the total integrated peak area in the chromatogram. It is a relative measure. It says that, among the UV-absorbing species the method detected, 99% of the signal belongs to your peptide and 1% belongs to related impurities.

That is genuinely useful information, but it is bounded by what the method can see. HPLC purity does not, by itself, account for non-peptide material that does not produce a comparable UV signal — water, residual salts, and counter-ions left over from synthesis and purification. This is why purity and content are two different conversations.

Peptide content (sometimes called net peptide content) answers a different question: of the total mass of powder in the vial, how much is actually peptide? Lyophilized peptides routinely carry trifluoroacetate (TFA) counter-ions from purification, bound water, and salts. Depending on the sequence and process, the actual peptide can be a meaningful fraction below the gross weight of the solid.

So a vial can be simultaneously 99% pure by HPLC (the peptide present is very clean) and, say, 80% peptide by content (a fifth of the powder's mass is water and salts). Both numbers can be true at once because they measure different things. For careful quantitative work, content is what determines how much peptide you actually have; purity tells you how clean that peptide is. A thorough COA reports them separately, and conflating them — or reporting only the more flattering one — is a common way listings overstate what is in the vial.

The standard purity measurement is reversed-phase HPLC with UV detection at 214 nm, the wavelength at which the peptide backbone absorbs. The analyst integrates the area under each peak and expresses the main peak as a percentage of the total. Method parameters matter: the column chemistry, the gradient, the run length, and the detection wavelength all influence which impurities are resolved and counted. A short, shallow gradient can hide closely-eluting impurities under the main peak and inflate the apparent purity, which is one reason the method details on a COA are worth reading, not just the headline figure.

Mass spectrometry complements purity by confirming identity and by revealing mass-related impurities — for example deletion sequences missing one residue, which show up as peaks at predictable mass differences. Purity and identity together are far more informative than either alone.

Reaching very high purity in solid-phase peptide synthesis requires good coupling chemistry and effective purification, usually preparative HPLC. The impurities that survive into the final product are typically structurally similar to the target — truncated or deletion sequences — which is exactly why they are hard to remove and why they can interfere with research results. An impurity that is a one-residue-shorter version of your peptide may have measurable, confounding activity in a sensitive assay.

This is the research case for caring about the difference between, say, 95% and 99% purity: in quantitative or mechanistic work, the identity and behavior of the few percent of impurity can be as important as the purity figure itself. The defensible position is not to trust a number on a label but to read the batch COA, see the chromatogram, and confirm the mass.